Experienced in Bartter Syndrome

Chun M. Chen

381 Wushan Road, 
Guangzhou, CN 
Experienced in Bartter Syndrome
381 Wushan Road, 
Guangzhou, CN 
OverviewLocationsClinical Research

Overview

Chun Chen practices in Guangzhou, China. Chen is rated as an Experienced expert by MediFind in the treatment of Bartter Syndrome. Their top areas of expertise are Esophageal Cancer, Thymic Epithelial Tumor, Lung Cancer, Thymectomy, and Lymphadenectomy.

Their clinical research consists of co-authoring 487 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Bartter Syndrome.

Locations

381 Wushan Road, Guangzhou, 510640, China
Other Locations
Science Island Branch, Hefei, 230026, China
Island Research Center, Tancheng, 350400, China
Chazhong Road 20, Fuzhou, 350005, China
Fujian Medical University Union Hospital
China
130 Dong An Road, Shanghai, 200032, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Multicenter Randomized Controlled Study of Neo-adjuvant Chemotherapy Paclitaxel + Cisplatin Versus Surgery Alone for Stage IIA-IIIB Esophageal Squamous Cell Carcinoma
A Phase III, Multicenter Randomized Controlled Study of Neo-adjuvant Chemotherapy Paclitaxel + Cisplatin Versus Surgery Alone for Stage IIA-IIIB Esophageal Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: October 05, 2022
Intervention Type: Drug
Study Drugs: Cisplatin, Paclitaxel
Study Phase: Phase 3

487 Total Publications

Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3).
Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3).
Journal: BMJ open
Published: October 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chen's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 77 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile